This is where targeted metabolic support can make a difference, breaking this vicious cycle by suppressing appetite, stabilizing blood sugar fluctuations, and reactivating satiety signals
Some people taking semaglutide report mild itching or skin tingling, though these experiences are less frequent than gastrointestinal symptoms
This approach isn't suitable for everyone, particularly those with diabetes on insulin or sulfonylureas, pregnant or breastfeeding women, people with a history of eating disorders, those with kidney disease, or frail individuals
55,58 However, postmarketing data on exenatide indicate an increase in INR, which is sometimes associated with bleeding events, highlighting the need for close INR monitoring after GLP-1 RA treatment